Evaluating the impact of GLP-1 agonists like semaglutide on central nervous system inflammation in MS
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
How Wegovy Works and Dietary Considerations Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of the naturally occurring hormone GLP-1
Lastly, this study highlighted the decrease in brain inflammation and marked increase in glial cell activation [61], again illustrating the anti-inflammatory and neuroprotective properties of GLP-1
The evidence cited includes the patent's listing in the FDA Orange Book, public statements by Hims's CEO on an August 2024 investor call discussing GLP-1 patent cliffs and acknowledging that semaglutide was not going off patent, and a formal demand letter sent by Novo Nordisk on February 8, 2026, one day before filing
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes SIGN UP FREE Keywords injector,auto injector,auto-injector,autoinjector,injector device,injector pen,inject,semaglutide,diabetes,anti-diabetes,anti-diabetic,type 2 diabetes,Ozempic,Rybelsus,Wegovy,glycemic control,obesity,anti-obesity,weight management,weight loss,auto syringe,self-injectable,injectable,medication pen,medication,injection,pen,capped,needle,metabolic,syndrome,treatment,treat,therapy,tip,medicine,plunger,dose window,selection,dial,dose,disposable,button,at-home,one-use,spring-loaded syringes,syringe,actuator,self-administration,drug delivery,prefilled syringe,intramuscular,subcutaneous,single use,portable injector,medical device,medical equipment,medical instrument,medical apparatus,medical tool,medical appliance,content-refinement-GLP-1-expansion,Rybelsus,Wegovy,semaglutide Autoinjector (semaglutide) icon JPEG Autoinjector (semaglutide) icon PNG Autoinjector (semaglutide) icon SVG Autoinjector (semaglutide) icon GIF BioRender icons and templates meet journal, grant, and copyright standards
